CVS:NYE-CVS Health Corporation (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 54.01

Change

0.00 (0.00)%

Market Cap

USD 78.05B

Volume

5.91M

Analyst Target

USD 78.78
Analyst Rating

N/A

ducovest Verdict

Verdict

About

CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-09 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

+6.34 (+1.20%)

USD 469.12B
ELV Elevance Health Inc

+4.72 (+1.21%)

USD 90.78B
CNC Centene Corp

-0.03 (-0.05%)

USD 31.74B
MOH Molina Healthcare Inc

+2.45 (+0.86%)

USD 16.37B
OSCR Oscar Health Inc

+0.02 (+0.14%)

USD 4.10B
NEUE NeueHealth Inc

+0.03 (+0.41%)

USD 0.06B
CI Cigna Corp

+6.11 (+2.13%)

N/A
HUM Humana Inc

-7.53 (-2.74%)

N/A

ETFs Containing CVS

FXG First Trust Consumer Stap.. 5.08 % 0.64 %

-0.35 (0.45%)

USD 0.30B
XFVT:XETRA Xtrackers - FTSE Vietnam .. 4.04 % 0.00 %

-0.11 (0.45%)

USD 0.35B
EQRR ProShares Equities for Ri.. 3.00 % 0.35 %

+0.45 (+0.45%)

USD 0.01B
UNCU:LSE First Trust US Equity Inc.. 2.79 % 0.00 %

+0.12 (+0.45%)

USD 0.04B
ESN Essential 40 Stock ETF 2.60 % 0.00 %

+0.07 (+0.45%)

USD 0.08B
VMAX REX VolMAXX Long VIX Futu.. 1.90 % 0.00 %

+0.17 (+0.45%)

USD 0.05B
SSPY Exchange Listed Funds Tru.. 0.76 % 0.00 %

+0.29 (+0.45%)

USD 0.09B
SHUS Exchange Listed Funds Tru.. 0.76 % 0.00 %

+0.24 (+0.45%)

USD 0.03B
LUSC:LSE SPDR Barclays 10+ U.S. Co.. 0.43 % 0.00 %

+0.03 (+0.45%)

N/A
LCRP:LSE SPDR Barclays 10+ U.S. Co.. 0.42 % 0.00 %

+0.03 (+0.45%)

USD 0.08B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.41 % 0.00 %

-0.10 (0.45%)

N/A
SYBN:F SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

+0.07 (+0.45%)

USD 0.10B
SYBN:XETRA SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

+0.06 (+0.45%)

USD 0.10B
SYBR:F SSgA SPDR ETFs Europe I P.. 0.30 % 0.00 %

+0.04 (+0.45%)

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.30 % 0.00 %

+0.09 (+0.45%)

USD 0.23B
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.30 % 0.00 %

N/A

USD 0.40B
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

-0.03 (0.45%)

USD 0.91B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

N/A

N/A
ESGF 0.00 % 0.40 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

-0.02 (0.45%)

USD 0.05B
FAB First Trust Multi Cap Val.. 0.00 % 0.70 %

+0.30 (+0.45%)

USD 0.14B
FEX First Trust Large Cap Cor.. 0.00 % 0.61 %

+0.46 (+0.45%)

USD 1.32B
FTA First Trust Large Cap Val.. 0.00 % 0.61 %

+0.34 (+0.45%)

USD 1.21B
IBDL 0.00 % 0.10 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.40 (+0.45%)

N/A
ILTB iShares Core 10+ Year USD.. 0.00 % 0.06 %

N/A

USD 0.61B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

+0.03 (+0.45%)

N/A
PBI:CA Purpose Best Ideas 0.00 % 0.79 %

+0.09 (+0.45%)

CAD 0.01B
SPLB SPDR Barclays Long Term C.. 0.00 % 0.08 %

-0.02 (0.45%)

USD 0.90B
IG Principal Exchange-Traded.. 0.00 % 0.26 %

+0.07 (+0.45%)

USD 0.09B
IGLB iShares 10+ Year Investme.. 0.00 % 0.10 %

-0.04 (0.45%)

USD 2.67B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

+0.01 (+0.45%)

USD 2.59B
RTH VanEck Retail ETF 0.00 % 0.35 %

+3.08 (+0.45%)

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

+0.19 (+0.45%)

N/A
SDOG ALPS Sector Dividend Dogs.. 0.00 % 0.40 %

+0.27 (+0.45%)

USD 1.22B
SLQD iShares 0-5 Year Investme.. 0.00 % 0.06 %

+0.02 (+0.45%)

USD 2.19B
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

+0.01 (+0.45%)

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+0.32 (+0.45%)

N/A
ICAN 0.00 % 0.50 %

N/A

N/A
FEX:LSE First Trust US Large Cap .. 0.00 % 0.00 %

+8.00 (+0.45%)

USD 0.25B
FEXD:LSE First Trust US Large Cap .. 0.00 % 0.00 %

+6.00 (+0.45%)

USD 0.04B
FEXU:LSE First Trust Global Funds .. 0.00 % 0.00 %

-0.02 (0.45%)

USD 0.25B
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

+3.00 (+0.45%)

USD 0.09B
UINC:LSE First Trust US Equity Inc.. 0.00 % 0.00 %

+8.00 (+0.45%)

USD 0.31B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
XVTD:LSE Xtrackers - FTSE Vietnam .. 0.00 % 0.00 %

-0.27 (0.45%)

USD 0.25B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
ZPRU:XETRA SPDR MSCI USA Value UCITS.. 0.00 % 0.00 %

+0.32 (+0.45%)

USD 0.13B
XFVT:SW Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

-0.35 (0.45%)

USD 0.25B
GBLO 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.32% 100% F 96% N/A
Dividend Return 1.48% 100% F 75% C
Total Return 21.80% 100% F 97% N/A
Trailing 12 Months  
Capital Gain -29.23% 11% F 7% C-
Dividend Return 3.49% 100% F 52% F
Total Return -25.75% 22% F 8% B-
Trailing 5 Years  
Capital Gain -26.87% 17% F 21% F
Dividend Return 15.50% 100% F 52% F
Total Return -11.37% 33% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain 0.38% 33% F 34% F
Dividend Return 2.91% 56% F 35% F
Total Return 2.53% 100% F 57% F
Risk Return Profile  
Volatility (Standard Deviation) 29.66% 22% F 36% F
Risk Adjusted Return 9.82% 44% F 26% F
Market Capitalization 78.05B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 15.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.